Hyaluronan-enriched Medium and Euploid Blastocyst Transfers
Recruiting
N/A
Interventional Study
Infertility
Implantation Rate
Clinical Pregnancy Rate
Live Birth Rate
Blastocysts
FET
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 46
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 783 (estimated)
- Sponsor
- ART Fertility Clinics LLC · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
It has been proposed that enriching transfer media with hyaluronan (EmbryoGlue medium) improves pregnancy outcomes compared with media containing lower concentrations of this molecule. However, none of previous studies included preimplantation genetic testing for aneuploidy (PGT-A) embryos. In order to investigate the impact of this hyaluronan-enriched on pregnancy outcomes, it is essential to eva…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All frozen embryo transfer (FET) cycles with euploid blastocysts biopsied and vitrified on Day 5 after PGT-A.
* Rank of randomization based on embryo quality.
* Only hormonal replacement theraphy (HRT) cycle regimen.
* Women aged 18 years to 46 years.
* Having at least 1 chrom…
Contacts